Latest News On Legislation

Latest California Healthline Stories

Congress Tackles The Opioid Epidemic. But How Much Will It Help?

President Trump, speaking Monday, called for a tough-on-crime federal approach. Meanwhile, on Capitol Hill, legislative strategies to combat this pressing public health problem are gaining momentum, but experts are not certain these approaches will make a difference.

California’s Tax On Millionaires Yields Big Benefits For People With Mental Illness, Study Finds

The research, focused on Los Angeles County, casts a positive light on a 2004 initiative that expanded mental health services statewide. A recent state audit, however, suggested hundreds of millions of dollars from the initiative were piling up, left unspent by counties.

Podcast: KHN’s ‘What The Health?’ What Do The Budget, Idaho And FDA Chief Scott Gottlieb Have In Common?

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Stephanie Armour of The Wall Street Journal and Paige Winfield-Cunningham of The Washington Post discuss President Donald Trump’s budget plan and how some states are trying to stabilize the Affordable Care Act, while others are trying to violate it. Also, Rovner and KHN’s Sarah Jane Tribble interview Scott Gottlieb, commissioner of the Food and Drug Administration.

Podcast: KHN’s ‘What The Health?’ There’s A Really Big Health Bill In That Budget Deal

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Alice Ollstein of Talking Points Memo, Joanne Kenen of Politico and Margot Sanger-Katz of The New York Times discuss the health policy changes included in the just-concluded bipartisan budget deal on Capitol Hill. The panelists also talk about the final enrollment numbers for individual insurance purchased under the Affordable Care Act, and possible drug price proposals in President Donald Trump’s upcoming budget. Plus, Rovner interviews Andy Slavitt, who this week launched a health care advocacy group called “The United States of Care.”

As States Target High Drug Prices, Pharma Targets State Lawmakers

In Louisiana, the wining and dining of lawmakers by scores of pharma lobbyists proves a valuable lesson on how to win statehouse votes and influence profits, though their efforts fell short in California, which passed a drug transparency bill in 2017 despite massive opposition from drugmakers.